This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 3 of 23 for:    cancer | Studies received from 04/22/2016 to 04/22/2016

Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Brigham and Women's Hospital
Botswana Harvard Aids Institute
Botswana Ministry of Health
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Scott Dryden-Peterson, Harvard School of Public Health
ClinicalTrials.gov Identifier:
NCT02752061
First received: April 22, 2016
Last updated: May 13, 2016
Last verified: May 2016
  Purpose

Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival.

The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.


Condition Intervention
Neoplasms HIV Healthcare Disparity Other: Potlako intervention

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana

Further study details as provided by Scott Dryden-Peterson, Harvard School of Public Health:

Primary Outcome Measures:
  • Cancer stage [ Time Frame: 1 day visit ]
  • Time from initial clinic visit with cancer symptom/sign to entry into oncology care [ Time Frame: 1 day visit ]

Estimated Enrollment: 2600
Study Start Date: April 2016
Estimated Study Completion Date: April 2019
Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Kweneng East District
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in Kweneng East District during study period.
Other: Potlako intervention

Multicomponent intervention including:

  • provider training on early detection and diagnostic approaches to cancer
  • patient education on importance of obtaining timely cancer diagnosis
  • provision of a patient navigator to facilitate diagnosis and entry into care
  • provision of transportation support to vulnerable patients
No Intervention: All other districts
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in all other districts of Botswana (or Kweneng East prior to implementation of intervention).

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Citizen of Botswana
  • Suspected or diagnosed cancer

Exclusion Criteria:

  • Involuntary incarceration
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02752061

Locations
Botswana
Botswana Harvard AIDS Institute
Gaborone, Botswana
Sponsors and Collaborators
Harvard School of Public Health
Brigham and Women's Hospital
Botswana Harvard Aids Institute
Botswana Ministry of Health
Dana-Farber Cancer Institute
  More Information

Responsible Party: Scott Dryden-Peterson, Instructor, Research Affiliate, Harvard School of Public Health
ClinicalTrials.gov Identifier: NCT02752061     History of Changes
Other Study ID Numbers: BHP078
Study First Received: April 22, 2016
Last Updated: May 13, 2016

ClinicalTrials.gov processed this record on June 23, 2017